1. Home
  2. QD vs MBX Comparison

QD vs MBX Comparison

Compare QD & MBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QD
  • MBX
  • Stock Information
  • Founded
  • QD 2014
  • MBX 2018
  • Country
  • QD China
  • MBX United States
  • Employees
  • QD N/A
  • MBX N/A
  • Industry
  • QD Finance: Consumer Services
  • MBX
  • Sector
  • QD Finance
  • MBX
  • Exchange
  • QD Nasdaq
  • MBX NYSE
  • Market Cap
  • QD 433.7M
  • MBX 347.9M
  • IPO Year
  • QD 2017
  • MBX 2024
  • Fundamental
  • Price
  • QD $2.52
  • MBX $7.62
  • Analyst Decision
  • QD
  • MBX Strong Buy
  • Analyst Count
  • QD 0
  • MBX 5
  • Target Price
  • QD N/A
  • MBX $37.40
  • AVG Volume (30 Days)
  • QD 518.3K
  • MBX 339.5K
  • Earning Date
  • QD 06-12-2025
  • MBX 05-16-2025
  • Dividend Yield
  • QD N/A
  • MBX N/A
  • EPS Growth
  • QD N/A
  • MBX N/A
  • EPS
  • QD 0.03
  • MBX N/A
  • Revenue
  • QD $32,502,011.00
  • MBX N/A
  • Revenue This Year
  • QD N/A
  • MBX N/A
  • Revenue Next Year
  • QD N/A
  • MBX N/A
  • P/E Ratio
  • QD $93.98
  • MBX N/A
  • Revenue Growth
  • QD 4.27
  • MBX N/A
  • 52 Week Low
  • QD $1.52
  • MBX $4.81
  • 52 Week High
  • QD $3.34
  • MBX $27.50
  • Technical
  • Relative Strength Index (RSI)
  • QD 48.02
  • MBX N/A
  • Support Level
  • QD $2.43
  • MBX N/A
  • Resistance Level
  • QD $2.74
  • MBX N/A
  • Average True Range (ATR)
  • QD 0.17
  • MBX 0.00
  • MACD
  • QD 0.02
  • MBX 0.00
  • Stochastic Oscillator
  • QD 68.57
  • MBX 0.00

About QD Qudian Inc. each representing one

Qudian Inc is a consumer-oriented technology company engaged in the operation of online platforms to provide small consumer credit products in the People's Republic of China. It aims to empower financial institutions with its technological capabilities, help them improve marketing and operating efficiency, and enable financial institutions to efficiently connect their diversified financial products with scene traffic across the entire network It derives a majority of its revenue from the People's Republic of China.

About MBX MBX BIOSCIENCES INC

MBX Biosciences Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291.

Share on Social Networks: